Influence of serotonin 3A and 3B receptor genes on ciozapine treatment response in schizophrenia

Pharmacogenetics and Genomics

Volumn 20, Issue 4, 2010, Pages 274-276

  Souza, Renan R ^a,b   De Luca, Vincenzo ^a,b   Meltzer, Herbert Y ^c   Lieberman, Jeffrey A ^d   Kennedy, James L ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c VANDERBILT UNIVERSITY   (United States)

^d NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

5 HTR3A; 5 HTR3B; Antipsychotic; BPRS; Pharmacogenetics; Pharmacogenomics; Response; Serotonin receptor; Treatment outcome

Indexed keywords

CLOZAPINE; SEROTONIN 3A RECEPTOR; SEROTONIN 3B RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG TOLERABILITY; FEMALE; GENE MUTATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEPTOR GENE; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; ALLELES; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DRUG RESISTANCE; FEMALE; GENETIC VARIATION; HUMANS; MALE; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, SEROTONIN, 5-HT3; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 77950670859     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e328337ce3e     Document Type: Article

References (10)

1. Briskin JK, Curtis JL Augmentation of clozapine therapy with ondansetron. Am J Psychiatry 1997; 154:1171.
2. Bymaster FP, Calligaro DO, Falcone JF, Marsh RD, Moore NA, Tye NC, ef al/. Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 1996; 14:87-96. (Pubitemid 26053226)
3. Schuhmacher A, Mossner R, Quednow BB, Kuhn KU, Wagner M, Cvetanovska G, et al. Influence of 5-HT3 receptor subunit genes HTR3A, HTR3B, HTR3C, HTR3D and HTR3E on treatment response to antipsychotics in schizophrenia. Pharmacogenet Genomics 2009; 19:843-851.
4. Ji X, Takahashi N, Saito S, lshihara R, Maeno N, lnada T, Ozaki N. Relationship between three serotonin receptor subtypes (HTR3A, HTR2A and HTR4) and treatment-resistant schizophrenia in the Japanese population. Neurosci Lett 2008; 435:95-98.
5. Ji X, Takahashi N, Branko A, lshihara R, Nagai T, Mouri A, et al. An association between serotonin receptor 3B gene (HTR3B) and treatment-resistant schizophrenia (TRS) in a Japanese population. Nagoya J Med SciI 2008; 70:11-17.
6. Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatmentresistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988; 45:789-796.
7. Souza RP, Romano-Silva MA, Lleberman JA, Meltzer HY, Wong AH, Kennedy JL Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response. Psychopharmacology (Berl) 2008; 200:177-186.
8. Gutierrez B, Arranz MJ, Huezo-Diaz P, Dempster D, Matthiasson P, Travis M, et al. Novel mutations in 5-HT3A and 5-HT3B receptor genes not associated with clozapine response. Schizophr Res 2002; 58:93-97.
9. Niesler B, Flohr T, Nothen MM, Fischer C, Rletschel M, Franzek E, et al. Association between the 5' UTR variant C178T of the serotonin receptor gene HTR3A and bipolar affective disorder. Pharmacogenetics 2001 ; 11:471-476.
10. lidaka T, Ozaki N, Matsumoto A, Nogawa J, Kinoshita Y, Suzuki T, et al. A variant C178T in the regulatory region of the serotonin receptor gene HTR3A modulates neural activation in the human amygdala. J Neurosci 2005; 25:6460-6466.